 Joseph Kay
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 20 | 2022 | 671 | 1.770 |
Why?
| | Transposition of Great Vessels | 7 | 2023 | 29 | 1.200 |
Why?
| | Tetralogy of Fallot | 9 | 2018 | 81 | 0.950 |
Why?
| | Catheter Ablation | 8 | 2019 | 288 | 0.620 |
Why?
| | Atrial Fibrillation | 6 | 2022 | 322 | 0.600 |
Why?
| | Cardiac Catheterization | 7 | 2020 | 534 | 0.570 |
Why?
| | Fontan Procedure | 4 | 2019 | 157 | 0.550 |
Why?
| | Tachycardia, Ventricular | 5 | 2019 | 152 | 0.540 |
Why?
| | Pacemaker, Artificial | 3 | 2020 | 106 | 0.530 |
Why?
| | Stents | 4 | 2018 | 475 | 0.520 |
Why?
| | Cardiology | 2 | 2020 | 259 | 0.520 |
Why?
| | Pulmonary Valve | 5 | 2018 | 89 | 0.500 |
Why?
| | Aortic Coarctation | 2 | 2023 | 70 | 0.480 |
Why?
| | Heart Septal Defects, Atrial | 3 | 2013 | 51 | 0.400 |
Why?
| | Heart Valve Diseases | 3 | 2020 | 161 | 0.400 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2023 | 217 | 0.360 |
Why?
| | Heart Valve Prosthesis Implantation | 4 | 2018 | 174 | 0.340 |
Why?
| | Arterial Switch Operation | 2 | 2022 | 5 | 0.340 |
Why?
| | Electrophysiologic Techniques, Cardiac | 7 | 2019 | 70 | 0.320 |
Why?
| | Sick Sinus Syndrome | 1 | 2009 | 2 | 0.320 |
Why?
| | Ultrasonography, Interventional | 2 | 2013 | 123 | 0.320 |
Why?
| | Thromboembolism | 2 | 2022 | 92 | 0.320 |
Why?
| | Adult | 40 | 2023 | 30544 | 0.320 |
Why?
| | Arrhythmias, Cardiac | 4 | 2019 | 279 | 0.320 |
Why?
| | Antiphospholipid Syndrome | 1 | 2009 | 26 | 0.310 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2009 | 109 | 0.310 |
Why?
| | Bradycardia | 1 | 2009 | 48 | 0.310 |
Why?
| | Catheterization | 2 | 2010 | 159 | 0.310 |
Why?
| | Coronary Angiography | 4 | 2013 | 304 | 0.300 |
Why?
| | Aneurysm, False | 1 | 2008 | 45 | 0.290 |
Why?
| | Treatment Outcome | 20 | 2022 | 9088 | 0.280 |
Why?
| | Follow-Up Studies | 13 | 2022 | 4411 | 0.280 |
Why?
| | Atrial Flutter | 3 | 2017 | 25 | 0.270 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2008 | 122 | 0.270 |
Why?
| | Cardiac Surgical Procedures | 4 | 2018 | 414 | 0.270 |
Why?
| | Forecasting | 2 | 2017 | 330 | 0.250 |
Why?
| | Heart Failure | 3 | 2023 | 1945 | 0.240 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 3 | 2016 | 28 | 0.240 |
Why?
| | Cryosurgery | 2 | 2018 | 52 | 0.230 |
Why?
| | Heart Rate | 3 | 2019 | 709 | 0.230 |
Why?
| | Pulmonary Valve Insufficiency | 3 | 2016 | 41 | 0.230 |
Why?
| | Retrospective Studies | 21 | 2023 | 12546 | 0.230 |
Why?
| | Risk Assessment | 5 | 2017 | 2968 | 0.220 |
Why?
| | Male | 38 | 2023 | 55583 | 0.220 |
Why?
| | Humans | 54 | 2023 | 114662 | 0.220 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2023 | 19 | 0.220 |
Why?
| | Electrocardiography | 7 | 2017 | 560 | 0.220 |
Why?
| | Echocardiography, Transesophageal | 3 | 2010 | 89 | 0.210 |
Why?
| | Female | 36 | 2023 | 59493 | 0.210 |
Why?
| | Prostheses and Implants | 1 | 2004 | 137 | 0.210 |
Why?
| | Anticoagulants | 3 | 2022 | 550 | 0.200 |
Why?
| | Myocardial Infarction | 1 | 2009 | 927 | 0.200 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2023 | 211 | 0.190 |
Why?
| | Young Adult | 16 | 2023 | 10466 | 0.190 |
Why?
| | Continuity of Patient Care | 3 | 2020 | 253 | 0.190 |
Why?
| | Heart Septal Defects, Ventricular | 2 | 2019 | 39 | 0.180 |
Why?
| | Postoperative Complications | 3 | 2019 | 2128 | 0.180 |
Why?
| | American Heart Association | 2 | 2017 | 264 | 0.180 |
Why?
| | Data Collection | 2 | 2013 | 620 | 0.180 |
Why?
| | Radiology, Interventional | 1 | 2020 | 26 | 0.170 |
Why?
| | Cardiologists | 1 | 2020 | 40 | 0.170 |
Why?
| | Liver Neoplasms | 1 | 2023 | 506 | 0.170 |
Why?
| | Hypertension | 2 | 2023 | 1056 | 0.160 |
Why?
| | Time Factors | 7 | 2019 | 6114 | 0.150 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2013 | 358 | 0.150 |
Why?
| | Patient Education as Topic | 2 | 2013 | 680 | 0.150 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2018 | 38 | 0.150 |
Why?
| | Marfan Syndrome | 2 | 2019 | 42 | 0.150 |
Why?
| | Preoperative Care | 2 | 2018 | 319 | 0.150 |
Why?
| | Middle Aged | 18 | 2023 | 26733 | 0.150 |
Why?
| | Aortic Valve Insufficiency | 2 | 2015 | 45 | 0.150 |
Why?
| | Heart Transplantation | 1 | 2023 | 665 | 0.140 |
Why?
| | Heart Ventricles | 2 | 2020 | 712 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 178 | 0.140 |
Why?
| | Tachycardia, Reciprocating | 1 | 2017 | 6 | 0.140 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 42 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 121 | 0.140 |
Why?
| | Survivors | 1 | 2020 | 411 | 0.140 |
Why?
| | Adolescent | 13 | 2023 | 17841 | 0.140 |
Why?
| | Hepatic Veins | 2 | 2016 | 29 | 0.140 |
Why?
| | Liver Transplantation | 1 | 2023 | 707 | 0.140 |
Why?
| | Aortic Valve Stenosis | 1 | 2020 | 272 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2020 | 368 | 0.130 |
Why?
| | Prevalence | 7 | 2019 | 2251 | 0.130 |
Why?
| | Aorta | 2 | 2023 | 386 | 0.130 |
Why?
| | Venous Thromboembolism | 1 | 2019 | 231 | 0.130 |
Why?
| | Tachycardia | 1 | 2016 | 50 | 0.130 |
Why?
| | Aortic Valve | 2 | 2020 | 398 | 0.130 |
Why?
| | Biomedical Research | 2 | 2013 | 585 | 0.120 |
Why?
| | Vectorcardiography | 1 | 2014 | 5 | 0.120 |
Why?
| | Pulmonary Veins | 1 | 2016 | 81 | 0.120 |
Why?
| | Radiography, Interventional | 2 | 2013 | 104 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 2285 | 0.120 |
Why?
| | Tricuspid Valve | 1 | 2014 | 25 | 0.110 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2013 | 4 | 0.110 |
Why?
| | Cardiac Resynchronization Therapy Devices | 1 | 2013 | 10 | 0.110 |
Why?
| | Heart-Assist Devices | 1 | 2020 | 485 | 0.110 |
Why?
| | Disease Management | 1 | 2017 | 560 | 0.110 |
Why?
| | Hypoxia | 1 | 2020 | 957 | 0.110 |
Why?
| | Antigens, Surface | 1 | 2013 | 146 | 0.110 |
Why?
| | Eisenmenger Complex | 1 | 2013 | 10 | 0.110 |
Why?
| | Portal Vein | 1 | 2014 | 76 | 0.110 |
Why?
| | Heart Atria | 1 | 2014 | 107 | 0.110 |
Why?
| | Cardiac Care Facilities | 1 | 2013 | 13 | 0.110 |
Why?
| | Electrodes, Implanted | 1 | 2013 | 91 | 0.110 |
Why?
| | Microbubbles | 1 | 2013 | 40 | 0.100 |
Why?
| | Prosthesis Design | 3 | 2018 | 285 | 0.100 |
Why?
| | Diastole | 1 | 2013 | 130 | 0.100 |
Why?
| | Predictive Value of Tests | 6 | 2014 | 1796 | 0.100 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2538 | 0.100 |
Why?
| | Sodium Chloride | 1 | 2013 | 136 | 0.100 |
Why?
| | Age Factors | 5 | 2017 | 2894 | 0.100 |
Why?
| | Mental Disorders | 1 | 2019 | 892 | 0.090 |
Why?
| | Aortic Diseases | 1 | 2012 | 106 | 0.090 |
Why?
| | Therapy, Computer-Assisted | 1 | 2011 | 58 | 0.090 |
Why?
| | Exercise Test | 3 | 2023 | 544 | 0.090 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 98 | 0.090 |
Why?
| | Internship and Residency | 1 | 2020 | 926 | 0.090 |
Why?
| | Heart Diseases | 3 | 2013 | 331 | 0.090 |
Why?
| | Angioplasty, Balloon | 1 | 2011 | 88 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 2 | 2011 | 511 | 0.090 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2011 | 64 | 0.090 |
Why?
| | Echocardiography | 1 | 2013 | 553 | 0.090 |
Why?
| | Prospective Studies | 7 | 2018 | 6219 | 0.090 |
Why?
| | Child | 10 | 2023 | 18412 | 0.090 |
Why?
| | Patient Participation | 1 | 2013 | 359 | 0.080 |
Why?
| | Risk Factors | 7 | 2019 | 8632 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 868 | 0.080 |
Why?
| | Pregnancy Outcome | 1 | 2011 | 337 | 0.080 |
Why?
| | Anti-Arrhythmia Agents | 2 | 2019 | 106 | 0.080 |
Why?
| | Chest Pain | 1 | 2009 | 81 | 0.080 |
Why?
| | Equipment Failure | 1 | 2009 | 106 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1141 | 0.080 |
Why?
| | Child, Preschool | 6 | 2019 | 9114 | 0.070 |
Why?
| | Cross-Sectional Studies | 6 | 2013 | 4408 | 0.070 |
Why?
| | Multicenter Studies as Topic | 1 | 2008 | 249 | 0.070 |
Why?
| | Aged | 7 | 2020 | 19069 | 0.070 |
Why?
| | Cardiopulmonary Bypass | 1 | 2008 | 178 | 0.070 |
Why?
| | Fosinopril | 1 | 2006 | 1 | 0.070 |
Why?
| | United States | 6 | 2018 | 12181 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1015 | 0.060 |
Why?
| | Physicians | 1 | 2013 | 772 | 0.060 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 179 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 1183 | 0.060 |
Why?
| | Altitude | 1 | 2008 | 432 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 668 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2019 | 6345 | 0.060 |
Why?
| | International Normalized Ratio | 1 | 2022 | 45 | 0.050 |
Why?
| | Vitamin K | 1 | 2022 | 42 | 0.050 |
Why?
| | Pulmonary Atresia | 2 | 2012 | 20 | 0.050 |
Why?
| | Cohort Studies | 2 | 2022 | 4895 | 0.050 |
Why?
| | Health Services Accessibility | 1 | 2007 | 762 | 0.050 |
Why?
| | Hemodynamics | 2 | 2018 | 1012 | 0.050 |
Why?
| | Arteries | 1 | 2022 | 247 | 0.040 |
Why?
| | Exercise | 1 | 2011 | 1644 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1430 | 0.040 |
Why?
| | Neoplasms | 1 | 2013 | 2097 | 0.040 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 234 | 0.040 |
Why?
| | Ultrasonography | 2 | 2014 | 634 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2014 | 1692 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4099 | 0.040 |
Why?
| | Gonadal Dysgenesis | 1 | 2019 | 8 | 0.040 |
Why?
| | Philadelphia | 1 | 2019 | 46 | 0.040 |
Why?
| | DiGeorge Syndrome | 1 | 2019 | 18 | 0.040 |
Why?
| | Prader-Willi Syndrome | 1 | 2019 | 25 | 0.040 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2019 | 56 | 0.040 |
Why?
| | Fragile X Syndrome | 1 | 2019 | 64 | 0.040 |
Why?
| | Mood Disorders | 1 | 2019 | 112 | 0.040 |
Why?
| | Hemorrhage | 1 | 2022 | 620 | 0.040 |
Why?
| | Quebec | 1 | 2017 | 5 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 537 | 0.040 |
Why?
| | Perioperative Period | 1 | 2017 | 49 | 0.040 |
Why?
| | Heart Conduction System | 1 | 2017 | 80 | 0.030 |
Why?
| | Reoperation | 1 | 2019 | 514 | 0.030 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2020 | 241 | 0.030 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2017 | 54 | 0.030 |
Why?
| | Blood Pressure | 1 | 2023 | 1538 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 935 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 2019 | 303 | 0.030 |
Why?
| | Action Potentials | 1 | 2019 | 406 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2016 | 250 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 442 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 255 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 122 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 574 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 174 | 0.030 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 220 | 0.030 |
Why?
| | Down Syndrome | 1 | 2019 | 335 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 953 | 0.030 |
Why?
| | Health Surveys | 1 | 2016 | 443 | 0.030 |
Why?
| | Curriculum | 1 | 2020 | 819 | 0.030 |
Why?
| | Cost of Illness | 1 | 2016 | 254 | 0.030 |
Why?
| | Kidney Diseases | 1 | 2017 | 350 | 0.030 |
Why?
| | Clinical Competence | 1 | 2020 | 893 | 0.030 |
Why?
| | Prostatectomy | 1 | 2013 | 98 | 0.030 |
Why?
| | Phlebography | 1 | 2013 | 34 | 0.030 |
Why?
| | Sinus of Valsalva | 1 | 2012 | 11 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2013 | 62 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2013 | 242 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2012 | 55 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 304 | 0.030 |
Why?
| | Prosthesis Implantation | 1 | 2013 | 138 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2013 | 92 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2013 | 195 | 0.030 |
Why?
| | Fluoroscopy | 1 | 2013 | 139 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1841 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 433 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2013 | 523 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 923 | 0.020 |
Why?
| | Cineangiography | 1 | 2011 | 16 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 811 | 0.020 |
Why?
| | Substance-Related Disorders | 1 | 2019 | 947 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1147 | 0.020 |
Why?
| | Infant | 3 | 2008 | 7961 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 208 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 740 | 0.020 |
Why?
| | Incidence | 1 | 2016 | 2313 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1167 | 0.020 |
Why?
| | Septal Occluder Device | 1 | 2010 | 46 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1629 | 0.020 |
Why?
| | Contrast Media | 1 | 2011 | 345 | 0.020 |
Why?
| | Tricuspid Atresia | 1 | 2008 | 6 | 0.020 |
Why?
| | Venae Cavae | 1 | 2008 | 9 | 0.020 |
Why?
| | Vena Cava, Superior | 1 | 2008 | 21 | 0.020 |
Why?
| | Pilot Projects | 1 | 2013 | 1373 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 136 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2011 | 588 | 0.020 |
Why?
| | Linear Models | 1 | 2010 | 768 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1040 | 0.020 |
Why?
| | Treatment Failure | 1 | 2008 | 331 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1518 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2710 | 0.020 |
Why?
| | Patient Selection | 1 | 2010 | 641 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 921 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2387 | 0.020 |
Why?
| | Pulmonary Circulation | 1 | 2008 | 407 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2763 | 0.020 |
Why?
| | Prognosis | 1 | 2013 | 3329 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2007 | 243 | 0.020 |
Why?
| | Quality of Life | 1 | 2016 | 2353 | 0.020 |
Why?
| | Length of Stay | 1 | 2008 | 962 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2008 | 683 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3046 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 1842 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2006 | 1660 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 4622 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 5518 | 0.010 |
Why?
| | Body Mass Index | 1 | 2006 | 1958 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2003 | 931 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2008 | 5045 | 0.010 |
Why?
|
|
Kay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|